Stock Taper
QuidelOrtho develops and manufactures diagnostic testing technologies across healthcare, including labs, transfusion medicine, point-of-care, and molecular diagnostics, serving global markets through direct and distributor channels.

The VITROS® XT 7600 is a high-throughput, integrated platform performing over 160 clinical chemistry and immunoassay tests, valued for its efficiency, reliability, and comprehensive testing capabilities in clinical laboratories.
| Icon | PRODUCT | Q4-2023 | Q1-2024 | Q2-2024 | Q3-2024 |
|---|---|---|---|---|---|
![]() | Other | $235.7M | $116.2M ▼ | $124.2M ▲ | $126.5M ▲ |
| Map | REGION | FY2013 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
![]() | North America Segment | — | $1.88B | $1.62B ▼ | $1.49B ▼ |
![]() | Other | — | $483.3M | — | — |
![]() | Emea Segment | — | $327.3M | $335.8M ▲ | $360.7M ▲ |
![]() | China Segment | — | — | $325M | $334.7M ▲ |
![]() | CHINA | — | $310.1M | — | — |
![]() | Latin America Segment | — | — | — | $252.9M |
![]() | Domestic Country | $152.71M | — | — | — |
![]() | Foreign Country | $22.7M | — | — | — |
Overall rating: C+
| PEER | PRICE | |
|---|---|---|
TWST | $141.38 | COMPARE |
EWTX | $42.76 | COMPARE |
QURE | $48.72 | COMPARE |
GPCR | $47.37 | COMPARE |
VRDN | $23.08 | COMPARE |
ATRC | $48.54 | COMPARE |
XRAY | $11.12 | COMPARE |
LMAT | $80.45 | COMPARE |